Few overheating or already-surging signals — relatively calm. A good stage to observe pre-breakout conditions patiently.
Some risk factors present — volatility, short-term overheating, or thin liquidity. Size and scale in carefully if entering.
Already surged, RSI overheated, extended far from highs, or earnings imminent. Chasing now carries meaningful pullback risk.
NERV's RSI(14) currently reads 46. RSI compares the size of recent up moves to down moves to flag stretched conditions in either direction. Readings above 70 are typically read as overbought and below 30 as oversold — this one falls in the 'normal' range. Treat this as one data point on NERV, not a standalone signal. → Learn more
ADX currently reads 23. ADX quantifies how strongly a trend is persisting, independent of whether it's up or down (25+ is considered pronounced). Right now NERV shows +DI sits above -DI, favoring the upside, putting it in the 'weak trend' range on ADX. This reading is specific to NERV on this scan date and can change quickly. → Learn more
NERV's Bollinger Band width is at the 37th percentile (mid-range) of its past year, and the squeeze indicator is not currently active. Band-width contraction (a squeeze) means the stock has been trading in an unusually tight range lately. A squeeze is often followed by a volatility expansion in either direction. This reading is specific to NERV on this scan date and can change quickly. → Learn more
NERV's OBV is currently rising (2.3x), and the up/down volume ratio is 2.3x. OBV adds volume on up days and subtracts it on down days, building a running estimate of money flow. This reading is specific to NERV on this scan date and can change quickly. → Learn more
NERV's recent volume is running at 0.4x its usual level. This ratio shows how many times normal volume the stock has been trading at lately — a reference point for whether order flow is concentrating around this stock. Treat this as one data point on NERV, not a standalone signal. → Learn more
NERV's change over the last 5 trading days is -4.2%, and over the last 1 trading day is -1.4%. Both figures describe short-term price movement only and are not, on their own, a trading signal.
NERV's current price is 22.4% below its 20-day high. This gap to the recent high is often watched as a proxy for nearby resistance. On this measure it currently falls in the 'distance from high' category. Treat this as one data point on NERV, not a standalone signal. → Learn more
NERV's ATR% currently reads 8.0%, a 'daily range' level. ATR (Average True Range) measures the average size of a stock's daily price swings. This reading is specific to NERV on this scan date and can change quickly. → Learn more
NERV's 20-trading-day relative strength versus SPY (S&P 500 ETF) is -4.7%. This means the stock's return trailed SPY's return over the same window. Treat this as one data point on NERV, not a standalone signal. → Learn more
Measured (n=6001), the hit-rate for OBV Accumulation (26.5%) was not statistically distinguishable from the base rate (29.3%). As with any single metric, weigh this alongside NERV's full indicator set. → OBV Accumulation
Measured (n=8370), the hit-rate for +DI Dominance (27.0%) was not statistically distinguishable from the base rate (29.3%). This reading is specific to NERV on this scan date and can change quickly. → +DI Dominance
No significant edge was measured for Weekly Squeeze: 25.4% versus a 29.3% base rate across 5281 cases. Cross-check this against NERV's other indicators above before drawing a conclusion. → Weekly Squeeze
Among stocks holding Avg Daily Range 4%+, 59.5% reached +15% within 20 trading days — significantly above the full-universe base rate of 29.3% (2502 cases measured). As with any single metric, weigh this alongside NERV's full indicator set. → Avg Daily Range 4%+
Limitations of this page — Automatically calculated, not a stock recommendation. Score is a count of conditions met, not a prediction; base rates are historical measurements only (NERV diagnostic as of 2026.09.09 15:08).
A history of past monitoring candidates — not investment advice. See the scanner's full track record here.